More Cyclopharm Limited news
Cyclopharm LimitedASX: CYC

S&P DJI Announces March 2022 Quarterly Rebalance

Mar 4, 2022 at 6:22 AM EST · Issued by Cyclopharm Limited

Filed with ASX · Mar 4, 2022 at 6:22 AM EST · 10 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2022-quarterly-rebalance-79

Cyclopharm Limited on 6ix

Story so far

  • S&P DJI Announces March 2021 Quarterly RebalanceMar 12, 2021

Earlier from Cyclopharm

  • Cyclopharm USFDA UpdateFeb 3, 2022
  • Half Year 2021 Financial ResultsAug 22, 2021
  • CYC First Half Trading UpdateJul 1, 2021
  • Managing Directors Address to ShareholdersMay 4, 2021
  • CYC 2021 AGM PresentationMay 4, 2021

Later from Cyclopharm

  • 1H 2022 Business Update - Record RevenuesJul 4, 2022
  • Technegas Used In Multicenter COVID StudyJul 6, 2022
  • Half Year 2022 ResultsAug 16, 2022
  • Cyclopharm Receives $1.64m R&D RefundNov 29, 2022
  • Dividend/Distribution - CYCFeb 20, 2023
All Cyclopharm news releases↗

Follow Cyclopharm into a list and get an email when it puts out news.

Follow Cyclopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer